Listen & subscribe

Breast Cancer Briefing, hosted by Sara Nunnery, MD, MSCI, is a podcast series that breaks down the latest news in breast cancer research, one conversation at a time.

www.onclive.com/podcasts/breast-cance...

Breast Cancer Briefing

Science

8 episodes

S1 Ep8: ESR1 Mutations Steer the Oral SERD Story in Breast Cancer: With Sara Nunnery, MD, MSCI; and MinhTri Nguyen, MD

Drs Nunnery and Nguyen discuss the emergence of the oral SERD giredestrant in hormone receptor–positive, HER2-negative breast cancer management.

38m • Jul 07

38m

S1 Ep7: SERENA-6 Splits the Breast Cancer Field on Switching Therapy Before Radiographic Progression: With Sara Nunnery, MD, MSCI; and Megan Kruse, MD

45m • Jun 30

45m

S1 Ep6: Oral SERDs Transform Metastatic Breast Cancer Management: With Sara Nunnery, MD, MSCI; and Vandana G. Abramson, MD

44m • Jun 16

44m

S1 Ep5: Honesty and Humor Provide Hope in Breast Cancer Survivorship: With Sara Nunnery, MD, MSCI; and Annie Bond

Dr Nunnery and Annie Bond discuss breast cancer survivorship and patient advocacy.

49m • May 12

49m

S1 Ep4: ADCs Change Treatment Paradigms and Challenge Standard AE Management Protocols in TNBC: With Sara Nunnery, MD, MSCI; and Irene Morae Kang, MD

Drs Nunnery and Kang discuss the rapidly evolving treatment paradigm for first-line metastatic TNBC, including the emergence of novel ADCs.

47m • Apr 30

47m

S1 Ep3: Evolving Research Puts a Focus on GLP-1 Agonist Use in Breast Cancer: With Sara Nunnery, MD, MSCI; and Neil M. Iyengar, MD

Drs Nunnery and Iyengar highlight the evolving integration of GLP-1 agonists into the breast cancer treatment armamentarium.

24m • Apr 28

24m

S1 Ep2: Lifestyle Interventions, Exercise Programs, and Metabolic Medications Are Key to Holistic Breast Cancer Survivorship: With Sara Nunnery, MD, MSCI; and Neil M. Iyengar, MD

Drs Nunnery and Iyengar discuss lifestyle and medical interventions pertinent to breast cancer survivorship.

27m • Apr 02

27m

S1 Ep1: T-DXd Trials Transform Treatment for HER2-Positive Breast Cancer: With Sara Nunnery, MD, MSCI; and Kelly E. McCann, MD, PhD

Drs Nunnery and McCann discuss the evolving HER2-positive breast cancer treatment paradigm.

43m • Mar 26

43m

This site uses Javascript

Please enable it in your browser's preferences.

You can visit our support center if you're having problems.

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.